Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China

被引：0

作者：

Shuyi Wu

Nianxu Huang

Xia Chen

Shaojun Jiang

Wang Zhang

Wei Hu

Jun Su

Hengfen Dai

Ping Gu

Xiaohong Huang

Xiaoming Du

Ruijuan Li

Qiaowei Zheng

Xiangsheng Lin

Yanxia Zhang

Lang Zou

Yuxin Liu

Min Zhang

Xiumei Liu

Zhu Zhu

Jianjun Sun

Shanshan Hong

Weibin She

Jinhua Zhang

机构：

[1] Fujian Medical University Union Hospital,Department of Pharmacy

[2] Taikang Tongji(Wuhan) Hospital,Department of Pharmacy

[3] Fuling Hospital of Chongqing University,Department of Pharmacy

[4] Department of Pharmacy,Department of Pharmacy, Xinyang Central Hospital

[5] The First People’s Hospital of Changde City,Department of Pharmacy

[6] Xinyang Hospital Affiliated to Zhengzhou University,Department of Pharmacy

[7] The First Affiliated Hospital of Bengbu Medical College,Department of Pharmacy

[8] Affiliated Fuzhou First Hospital of Fujian Medical University,Department of Pharmacy

[9] Suining Central Hospital,Department of Pharmacy

[10] Zhangzhou Affiliated Hospital of Fujian Medical University,Department of Pharmacy, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital

[11] Shengjing Hospital of China Medical University,Department of Pharmacy

[12] Third Hospital of Shanxi Medical University,Department of Pharmacy

[13] First Affiliated Hospital of Xi’an Jiaotong University,Department of Pharmacy

[14] Pingtan County General Laboratory Area Hospital,Department of Pharmacy, Second Affiliated Hospital

[15] The First Affiliated Hospital of Jiamusi University,Department of Pharmacy

[16] Army Medical University,Department of Pharmacy, Affiliated Qingdao Third People’s Hospital

[17] Huaihe Hospital of Henan University,Department of Pharmacy

[18] Qingdao University,Department of Pharmacy

[19] People’s Hospital of He’nan University of Chinese Medicine (People’s Hospital of Zhengzhou),Department of Pharmacy

[20] The Second Affiliated Hospital of Soochow University,Department of Pharmacy

[21] Affiliated Hospital of Inner Mongolia Medical University,Department of Medical Administration

[22] Quanzhou First Hospital,undefined

[23] Dongguan Kanghua Hospital,undefined

来源：

Cardiovascular Drugs and Therapy | 2023年 / 37卷

关键词：

Atrial fibrillation; Body mass index; Direct oral anticoagulation; Bleeding; Thrombosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：715 / 727

页数：12

共 50 条

[21] Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study
Li, Xiaoye
Zuo, Chengchun
Ji, Qiuyi
Xue, Ying
Wang, Zi
Lv, Qianzhou
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1931 - 1943
[22] Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non-valvular atrial fibrillation
Thomsen, T. Alvaro
Guadalupe, J. Mesa
Huerta, C.
de Burgos, A.
Soriano, L. Cea
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
[23] Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation
Yuji Murakawa
Takanori Ikeda
Satoshi Ogawa
Takanari Kitazono
Jyoji Nakagawara
Kazuo Minematsu
Susumu Miyamoto
Yasuhiro Hayashi
Yoko Kidani
Yutaka Okayama
Toshiyuki Sunaya
Shoichiro Sato
Satoshi Yamanaka
Heart and Vessels, 2020, 35 : 1125 - 1134
[24] EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary
Heidbuchel, Hein
Verhamme, Peter
Alings, Marco
Antz, Matthias
Hacke, Werner
Oldgren, Jonas
Sinnaeve, Peter
Camm, A. John
Kirchhof, Paulus
EUROPEAN HEART JOURNAL, 2013, 34 (27) : 2094 - 2106
[25] Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation
Murakawa, Yuji
Ikeda, Takanori
Ogawa, Satoshi
Kitazono, Takanari
Nakagawara, Jyoji
Minematsu, Kazuo
Miyamoto, Susumu
Hayashi, Yasuhiro
Kidani, Yoko
Okayama, Yutaka
Sunaya, Toshiyuki
Sato, Shoichiro
Yamanaka, Satoshi
HEART AND VESSELS, 2020, 35 (08) : 1125 - 1134
[26] Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass Index
Hansson, Astrid Fritz
Eriksson, Karin Jensevik
Christersson, Christina
Held, Claes
Batra, Gorav
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (22):
[27] Influence of the COVID-19 pandemic on patients receiving oral anticoagulants for the treatment of non-valvular atrial fibrillation
Colet, Josep Comin
Mainar, Antoni Sicras
Salazar-Mendiguchia, Joel
Alonso, Maria Isabel del Campo
Echeto, Ainara
Larena, David Vilanova
Sanchez, Olga Delgado
IJC HEART & VASCULATURE, 2024, 51
[28] Direct oral anticoagulants use in elderly patients with non valvular atrial fibrillation: state of evidence
Benedetti, Giulia
Neccia, Matteo
Agati, Luciano
MINERVA CARDIOANGIOLOGICA, 2018, 66 (03): : 301 - 313
[29] Updates on new oral anticoagulants and percutaneous devices for stroke prevention in patients with non-valvular atrial fibrillation
Kwong, Joey S. W.
Lam, Yat-Yin
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 155 (02) : 340 - 341
[30] Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants
Chang, Kuo-Hsuan
Chen, Chiung-Mei
Wang, Chun-Li
Tu, Hui-Tzu
Huang, Yu-Tung
Wu, Hsiu-Chuan
Chang, Chien-Hung
Chang, Shang-Hung
FRONTIERS IN AGING NEUROSCIENCE, 2022, 14

← 1 2 3 4 5 →